|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Aeglea BioTherapeutics (NASDAQ: AGLE) through any online brokerage.
The latest price target for Aeglea BioTherapeutics (NASDAQ: AGLE) was reported by HC Wainwright & Co. on November 9, 2020. The analyst firm set a price target for 15.00 expecting AGLE to rise to within 12 months (a possible 128.66% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Aeglea BioTherapeutics (NASDAQ: AGLE) is $6.56 last updated Tue Jun 15 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Aeglea BioTherapeutics.
There is no upcoming split for Aeglea BioTherapeutics.
Aeglea BioTherapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.